Junctional Adhesion Molecule-A Is Required for Hematogenous Dissemination of Reovirus  by Antar, Annukka A.R. et al.
Cell Host & Microbe
ArticleJunctional Adhesion Molecule-A Is Required
for Hematogenous Dissemination of Reovirus
Annukka A.R. Antar,1,2 Jennifer L. Konopka,2,3 Jacquelyn A. Campbell,1,2 Rachel A. Henry,1 Ana L. Perdigoto,4,5
Bruce D. Carter,4,5 Ambra Pozzi,6,7,8 Ty W. Abel,9 and Terence S. Dermody1,2,3,*
1Department of Microbiology and Immunology
2Elizabeth B. Lamb Center for Pediatric Research
3Department of Pediatrics
4Department of Biochemistry
5Center for Molecular Neuroscience
6Department of Cancer Biology
7Department of Medicine
Vanderbilt University School of Medicine, Nashville, TN 37232, USA
8Department of Medicine, Veteran Affairs Hospital, Nashville, TN 37212, USA
9Department of Pathology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
*Correspondence: terry.dermody@vanderbilt.edu
DOI 10.1016/j.chom.2008.12.001SUMMARY
Diverse families of viruses bind immunoglobulin
superfamily (IgSF) proteins located in tight junctions
(TJs) and adherens junctions of epithelium and endo-
thelium. However, little is known about the roles of
these receptors in the pathogenesis of viral disease.
Junctional adhesion molecule-A (JAM-A) is an IgSF
protein that localizes to TJs and serves as a receptor
for mammalian reovirus. We inoculated wild-type
(WT) and isogenic JAM-A/ mice perorally with
reovirus and found that JAM-A is dispensable for viral
replication in the intestine but required for systemic
dissemination. Reovirus replication in the brain and
tropism for discrete neural regions are equivalent in
WT and JAM-A/ mice following intracranial inocu-
lation, suggesting a function for JAM-A in reovirus
spread to extraintestinal sites. JAM-A promotes
reovirus infection of endothelial cells, providing
a conduit for the virus into the bloodstream. These
findings indicate that a broadly expressed IgSF viral
receptor specifically mediates hematogenous
dissemination in the host.
INTRODUCTION
Diverse viruses use immunoglobulin superfamily (IgSF) mole-
cules as receptors (Vogelmann et al., 2004). Many of these
proteins localize to tight junctions (TJs) and adherens junctions
that link polarized cells. Junctional adhesion molecule-A (JAM-
A) is an IgSF member that serves as a receptor for feline calicivi-
rus (Makino et al., 2006) and all three serotypes of mammalian
orthoreovirus (reovirus) (Campbell et al., 2005). JAM-A localizes
to TJs of tissue endothelium and epithelium and also is found on
leukocytes and platelets (Kornecki et al., 1990; Martin-Padura
et al., 1998). JAM-A is comprised of two extracellular Ig-like
domains, a short transmembrane region, and a cytoplasmic tail
possessing a PDZ-domain-binding motif (Martin-Padura et al.,Cel1998). During an inflammatory response, JAM-A redistributes
from cellular junctions to the apical surface and engages circu-
lating leukocytes for diapedesis through endothelium (Weber
et al., 2007).
Reoviruses form nonenveloped, double-shelled particles con-
taining a genome of ten segments of double-stranded RNA
(Schiff et al., 2007). The viral S1 gene encodes the s1 protein,
which extends from the virion surface (Furlong et al., 1988) and
mediates viral attachment to host-cell receptors (Weiner et al.,
1980a; Lee et al., 1981). Virtually all mammals, including
humans, serve as hosts for reovirus infection (Virgin et al.,
1997). However, reovirus causes disease primarily in the very
young (Mann et al., 2002; Tyler et al., 2004). Reovirus is a highly
tractable experimental model for studies of viral pathogenesis
(Virgin et al., 1997) and has been used in clinical trials for the
treatment of aggressive human malignancies (Stoeckel and
Hay, 2006).
After inoculation of newborn mice, reovirus disseminates to
the central nervous system (CNS) and produces serotype-
specific patterns of disease. Type 1 (T1) reovirus spreads
primarily by hematogenous routes to the CNS, where it infects
ependymal cells, leading to nonlethal hydrocephalus (Weiner
et al., 1980b; Tyler et al., 1986). In contrast, type 3 (T3) reovirus
spreads by neural routes to the CNS and infects neurons,
causing lethal encephalitis (Weiner et al., 1980b; Tyler et al.,
1986; Morrison et al., 1991). The s1-encoding S1 gene dictates
these dichotomous dissemination and disease patterns (Weiner
et al., 1980b; Tyler et al., 1986), presumably by selective recog-
nition of cell-surface receptors by s1.
The s1 protein forms an elongated fiber with a compact glob-
ular head at the C terminus (Fraser et al., 1990; Chappell et al.,
2002). The s1 head mediates binding to JAM-A (Barton et al.,
2001b), whereas residues in the s1 tail, close to the midpoint
of the molecule, mediate binding of T3 s1 to sialic acid (Chappell
et al., 1998, 2000). A region in the tail just beneath the headmedi-
ates T1 s1 binding to a carbohydrate that has not been deter-
mined (Chappell et al., 2000). Residues in the membrane-distal
Ig domain of JAM-A that mediate homodimer formation are
required for efficient engagement of s1 (Forrest et al., 2003;
Guglielmi et al., 2007). Despite elucidation of these key structurall Host & Microbe 5, 59–71, January 22, 2009 ª2009 Elsevier Inc. 59
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JAM-A and Reovirus DisseminationFigure 1. JAM-A Is Required for Efficient Reovirus Infection of MEFs
(A) Primary MEFs generated from JAM-A+/+ and JAM-A/ embryos were adsorbed with reovirus T1L, T3D, or T3SA at MOIs of 0.01, 0.1, and 1
fluorescent focus unit (FFU)/cell and incubated for 20 hr. Reovirus antigen was detected by indirect immunofluorescence. Representative wells after adsorption
with 1 FFU/cell are shown.
(B) Infected cells were quantified in five fields of 2003 view for triplicate samples. Results are expressed as the mean FFU/field for triplicate experiments. Error
bars indicate SD *, p < 0.01 as determined by Student’s t test.
(C) Confluent monolayers of JAM-A+/+ and JAM-A/MEFs were adsorbed with reovirus T1L, T3D, or T3SA at an MOI of 2 pfu/cell and incubated for the times
shown. Viral titers were determined by plaque assay. Results are expressed as mean viral yields (tx/t0) for triplicate experiments. Error bars indicate SD.and functional aspects of reovirus-JAM-A interactions, the role
of JAM-A in reovirus pathogenesis is not yet fully defined.
In this study, we used wild-type (WT) and isogenic JAM-A-null
mice to define the function of JAM-A in reovirus disease. We
found that JAM-A is not necessary for viral replication in the
intestine after peroral inoculation, replication in the brain after
intracranial inoculation, or viral access to neural routes of
dissemination. However, JAM-A is required for efficient infection
of primary endothelial cells, establishment of viremia, and
systemic dissemination. These findings highlight a specific role
for junction-associated virus receptors in mediating hematoge-
nous viral dissemination within the infected host.60 Cell Host & Microbe 5, 59–71, January 22, 2009 ª2009 Elsevier IRESULTS
T1 and T3 Reoviruses Efficiently Infect WT
but Not JAM-A/ MEFs
To determine whether genetic deletion of JAM-A alters reovirus
infection of cells, we infected primary mouse embryonic
fibroblasts (MEFs) isolated from WT and isogenic JAM-A/
mice with T1 and T3 reovirus strains at various multiplicities of
infection (MOIs). We used prototype strains T1 Lang (T1L) and
T3 Dearing (T3D) and a reassortant virus, T3SA. The T3SA
genome consists of nine gene segments from T1L and the S1
gene segment from non-sialic-acid-binding strain T3C44 (Bartonnc.
Cell Host & Microbe
JAM-A and Reovirus DisseminationFigure 2. Reovirus T3SA Is Attenuated Following Peroral Inoculation of JAM-A/ Mice
(A and B) Newborn JAM-A+/+ and JAM-A/mice were inoculated perorally with 109 pfu of reovirus T3SA. Mice (n = 26 JAM-A+/+ and n = 16 JAM-A/) were
monitored for survival (A) and weight gain (B). *, p < 0.0001 as determined by log-rank test.
(C) Newborn JAM-A+/+ and JAM-A/ mice were inoculated perorally with 104 pfu T3SA. At days 4, 8, and 12 after inoculation, mice were euthanized,
organs were resected, and viral titers were determined by plaque assay. Results are expressed as mean viral titers for 6–13 animals for each time point. Error
bars indicate SD *, p < 0.05 by Student’s t test.
(D) One or two newborn JAM-A+/+ and two newborn JAM-A/mice from litters of 4–8 animals were inoculated perorally with 104 pfu T3SA and reunited with
uninoculated littermates. At day 12 after inoculation, mice were euthanized, intestines were resected, and viral titers were determined by plaque assay. Each data
point represents one animal. Horizontal bars indicate the arithmetic mean of log-transformed data.et al., 2001a). Like T3D, T3SA binds JAM-A and is neurotropic,
but unlike T3D, T3SA can replicate in the intestine and dissem-
inate systemically from that site (Barton et al., 2003). The
absence of JAM-A expression by JAM-A/ MEFs was
confirmed by immunoblotting (Figure S1). All strains of reovirus
were capable of infecting WT MEFs, but not JAM-A/ MEFs,
over the course of a single infectious cycle (Figures 1A and
1B). We quantified viral yields over several days and found that
JAM-A is required for efficient replication of reovirus in MEFs
(Figure 1C). T1 and T3 reovirus strains exhibit differences in
infection of cell types that segregate with viral proteins not
involved in receptor binding or cell entry (Matoba et al., 1991,
1993). However, strain T3D, which binds sialic acid (Dermody
et al., 1990), replicated to higher titer in JAM-A/ MEFs than
did reovirus strains T1L and T3SA, which do not bind this
carbohydrate (Dermody et al., 1990; Barton et al., 2001a), sug-
gesting that the capacity to bind sialic acid enhances reovirus
infection of MEFs.CeJAM-A Is Required for Lethal T3 Reovirus Disease
To determine the function of JAM-A in reovirus pathogenesis, we
compared susceptibility of WT and JAM-A/ mice to reovirus
infection and disease. We used T3SA, which is neurotropic
but incapable of binding sialic acid, to isolate the role of JAM-A
from the role of sialic acid in reovirus pathogenesis. Newborn
WTand JAM-A/micewere inoculatedperorallywith escalating
doses of T3SA, from 10 to 109 plaque-forming units (pfu), and
survival was assessed as a function of dose. The percentage of
WT mice that succumbed rose with increasing dose, yielding an
LD50 value of 1.9 3 10
7 pfu (Table S1). Infected mice developed
clinical signs of encephalitis, including lethargy, flaccid paralysis,
spastic movements, unsteady gait, and seizures. In sharp
contrast, no JAM-A/ animals succumbed to lethal encephalitis
following inoculation with T3SA at any dose tested (Table S1),
nor did any JAM-A/mouse demonstrate detectable neurolog-
ical signs. At the highest dose of T3SA tested, 109 pfu, the
majority of WT mice died, whereas all JAM-A/ mice survivedll Host & Microbe 5, 59–71, January 22, 2009 ª2009 Elsevier Inc. 61
Cell Host & Microbe
JAM-A and Reovirus Dissemination(Figure 2A). As a quantitative indicator of disease progression,
surviving WT mice inoculated with 109 pfu gained weight less
rapidly than similarly inoculated JAM-A/ mice (Figure 2B).
Taken together, these resultsdemonstrate that JAM-A is required
for lethal encephalitis following peroral inoculation of T3SA.
To determine the extent of viral replication in infectedmice, we
inoculated newborn WT and JAM-A/ mice perorally with 104
Figure 3. Reovirus T3SA Is Fully Virulent Following Intracranial
Inoculation of JAM-A/ Mice
(A and B) Newborn JAM-A+/+ and JAM-A/ mice were inoculated intracrani-
allywith 100pfu of reovirusT3SA. Mice (n= 40JAM-A+/+ and n=32 JAM-A/)
were monitored for survival (A) and weight gain (B).
(C) Newborn JAM-A+/+ and JAM-A/mice were inoculated intracranially with
100 pfu T3SA. At days 2, 4, 6, 8, and 10 after inoculation, mice were eutha-
nized, brains were resected, and viral titers were determined by plaque assay.
Results are expressed asmean viral titers for 5–13 animals for each time point.
Error bars indicate SD.62 Cell Host & Microbe 5, 59–71, January 22, 2009 ª2009 Elsevierpfu T3SA, a sub-LD50 value, and quantified viral titer in organs
at various intervals postinoculation. Titers in the intestine are
negligible at days 4 and 8 following peroral inoculation of reovirus
strains that do not replicate in the intestine, such as T3D (Bodkin
and Fields, 1989). Therefore, viral titer in the intestine at and after
4 days postinoculation is indicative of reovirus replication at that
site. Remarkably, T3SA produced equivalent titers of virus in
the intestine of WT and JAM-A/ mice. However, viral titers at
sites of secondary infection, including the spleen, liver, heart,
and brain, were substantially greater in WT animals than in
JAM-A/ mice (Figure 2C). Thus, following peroral inoculation,
JAM-A is dispensable for reovirus replication in the intestine
but is required for production of maximal reovirus titer at sites
of secondary infection, including the CNS.
To test whether JAM-A promotes transmission of reovirus
between infected and uninfected mice, we inoculated one or
two newborn WT and JAM-A/ mice from each of three litters
perorally with 104 pfu of T3SA and placed these animals with
their littermates immediately after inoculation. Viral titers in intes-
tines of inoculated and uninoculated mice were determined at
day 12 postinoculation. T3SA replication was observed in the
intestines of all inoculated WT and JAM-A/ mice (Figure 2D).
Remarkably, 17 of 17 uninoculated JAM-A/ littermates and
9 of 13 uninoculated WT littermates harbored viral titer in the
intestine (Figure 2D). These results indicate that JAM-A is not
required for transmission of reovirus between littermates.
JAM-A Is Required for Efficient Dissemination
of T3SA Reovirus
We thought it possible that reovirus might be incapable of either
dissemination to sites of secondary infection in JAM-A/ mice
or establishing infection once reaching those sites. To distin-
guish between these possibilities, we inoculated WT and
JAM-A/ mice intracranially with escalating doses of reovirus
T3SA and assessed survival as a function of dose. Both WT
and JAM-A/ mice succumbed to lethal encephalitis, yielding
LD50 values of 52 and 41 pfu, respectively (Table S2). At a dose
of 100 pfu T3SA delivered intracranially, WT and JAM-A/
animal survival and alterations in weight gain were statistically
indistinguishable (Figures 3A and 3B). Concordantly, reovirus
reached equivalent titer in the brains of WT and JAM-A/
mice following intracranial inoculation (Figure 3C). That reovirus
is incapable of replication in the brain of JAM-A/ mice
following peroral inoculation but fully virulent following direct
inoculation into the brain of these animals suggests a role for
JAM-A in systemic dissemination of reovirus from the intestine
to target organs.
T3 Reovirus Tropism in the Brain Is Not Altered
in JAM-A/ Mice
The s1-encoding S1 gene is the main determinant of reovirus
tropism within the CNS (Weiner et al., 1980b). To test whether
s1-JAM-A interactions are required for neural tropism of T3
reovirus, we compared histologic sections of brain from WT
and JAM-A/ mice inoculated intracranially with 104 pfu
T3SA. Brains chosen for histologic analysis were matched for
viral titer, and thin sections were matched anatomically based
on the size and shape of landmarks such as the hippocampus.
Hematoxylin and eosin (H&E)-stained sections showed aInc.
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JAM-A and Reovirus DisseminationFigure 4. Histopathology of Reovirus Infection Following Intracranial Inoculation
(A and B) Newborn JAM-A+/+ and JAM-A/ mice were inoculated intracranially with 104 pfu T3SA. Eight days after inoculation, brains of infected mice were
resected and bisected sagittally. The left hemisphere was prepared for viral titer determination by plaque assay, and the right hemisphere was processed for
histopathology. Consecutive coronal sections were stained with H&E or polyclonal reovirus antiserum. Representative sections of brain hemisphere, matched
for hippocampal depth (A) and cerebellum (B), are shown. Boxes indicate areas of enlargement on the right and show cortical neurons (A) and cerebellar Purkinje
neurons (B). JAM-A+/+ brain sections are from brains with left hemisphere viral titers of 4.13 109 pfu (A) and 3.03 109 pfu (B). JAM-A/ brain sections are from
brains with left hemisphere viral titers of 3.4 3 109 pfu (A) and 1.6 3 109 pfu (B).consistent pattern of injury and inflammation in both WT and
JAM-A/mice, indicative of encephalitis. In bothmouse strains,
neurons of the hippocampal pyramidal layers were affected,Celshowing abundant eosinophilic, cytoplasmic inclusions and indi-
vidual cell necrosis and apoptosis. Similar changes were
observed in cerebellar Purkinje layer neurons, with relativel Host & Microbe 5, 59–71, January 22, 2009 ª2009 Elsevier Inc. 63
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JAM-A and Reovirus Disseminationsparing of granule cells. Other regions consistently affected in
both strains of mice included the dorsal thalamic nuclei, hypo-
thalamus, and middle layers of the cerebral cortex (Figure 4).
Immunohistochemistry for reovirus antigen confirmed the pres-
ence of virus in hippocampal and cerebellar neurons and cells
with neuronal morphology in other affected regions (Figure 4).
Ependymal cells were spared in both genotypes of mice. The
reovirus antigen signal appeared more intense in the cortex,
especially the outer layers, and in the hippocampus of
JAM-A/ brain when compared to WT brain. There exists
some variability in the intensity of antigen staining in individual
animals from both strains of mice (Figure S2). However, reovirus
targeted the same cell types and brain regions in WT and
JAM-A/ animals. Therefore, JAM-A does not mediate target-
ing of reovirus to specific regions within the brain.
JAM-A Is Required for Efficient Dissemination
of T1L Reovirus
To determine whether JAM-A is required for dissemination of
reovirus T1L from intestine to brain, we inoculated WT and
JAM-A/ mice perorally with 106 pfu T1L and quantified viral
titer in organs at various intervals postinoculation. Like our
results with T3SA, titers of T1L in the intestines of JAM-A/
mice were similar to those in WT animals. Titers of T1L at sites
of secondary infection, including the spleen, liver, heart, and
brain, were substantially greater in WT animals than in JAM-
A/ mice. In fact, there was no detectable T1L titer in the brain
of JAM-A/mice (Figure 5A). To confirm that JAM-A is required
for T1L reovirus replication in the intestine, we compared histo-
logic sections of intestines from WT and JAM-A/ mice inocu-
lated perorally with 108 pfu T1L. In both mouse strains, epithelial
cells of intestinal villi were affected at early times postinocula-
tion, showing abundant eosinophilic, cytoplasmic inclusions
(Figure 5C). Immunohistochemistry for reovirus antigen
confirmed the presence of virus in villus epithelial cells (Figure 5C)
and mononuclear cells within Peyer’s patches (PPs) (Figure 5D).
To determine whether JAM-A is required for T1 reovirus
replication in the brain, we inoculated WT and JAM-A/ mice
intracranially with 103 pfu T1L and quantified viral titer in brain
homogenates. We found that T1L replicates to equivalent or
higher titer in the brain of JAM-A/ mice in comparison to WT
mice (Figure 5B). That T1L reovirus is incapable of replication
in the brains of JAM-A/ mice following peroral inoculation,
despite the capacity to replicate in the brain of these animals
following intracranial inoculation, indicates that JAM-A is
required for systemic dissemination of T1 reovirus from the
intestine.CeSpread of T1 but Not T3 Reovirus from Hindlimb
to Spinal Cord Is Blunted in JAM-A/ Mice
Surgical section of the sciatic nerve ablates spread of T3D but
not T1L to the inferior spinal cord (ISC) following inoculation
into the hindlimb, indicating that T3D spreads neurally to the
spinal cord, whereas T1L spreads primarily hematogenously to
that tissue (Tyler et al., 1986). To determine the mechanism by
which JAM-A promotes reovirus dissemination, we inoculated
WT and JAM-A/ mice into the hindlimb with 106 pfu of either
T1L or T3D and quantified viral titer in the hindlimb, blood, and
ISC. After inoculation with T3D, both WT and JAM-A/ mice
harbored high viral titers in the ISC and low titers in the blood,
consistent with an intact neural route of spread (Figure 6A).
The ratio of T3D titer in the ISC to titer in the hindlimb is lower
on day 8 in JAM-A/mice than inWT animals (Figure S3), which
may reflect accelerated clearance of T3D in the spinal cord of
JAM-A/ mice in comparison to WT animals. After inoculation
of T1L into WT mice, viral titers in blood and ISC increased virtu-
ally simultaneously over the experimental timecourse, consistent
with a hematogenous route of spread (Figure 6A). In contrast, the
titer of T1L in blood and ISC in JAM-A/ mice increased with
markedly reduced kinetics in comparison to the titer rise in WT
animals (Figure 6A). These findings suggest that JAM-A medi-
ates efficient hematogenous spread of reovirus from the hind-
limb but is not required for neural spread from hindlimb to ISC.
Primary Cultures of Cortical Neurons from WT
and JAM-A/ Mice Support Reovirus Infection
To directly test whether JAM-A is required for reovirus infection
of neurons, we infected primary cortical neuron cultures
prepared from embryonic WT and JAM-A/ mice with T1 and
T3 reovirus. The primary cortical neurons displayed classic
neuronal morphology and stained for the neuron-specific beta
III tubulin marker, TUJ1 (Figure 6B). The pattern of T3 reovirus
antigen staining was identical in WT and JAM-A/ cortical
neurons, which displayed similar morphology and characteris-
tics of reovirus infection (Figure 6B). In both types of neurons,
reovirus-positive inclusions were observed dotting the length
of infected axons, a staining pattern consistent with focal sites of
reovirus replication (Becker et al., 2003). The total percentage
of neurons infected by T3SA was equivalent in WT and
JAM-A/ cultures (Figure 6C). As a control, T1L was incapable
of infecting mouse cortical neurons regardless of JAM-A
expression (Figure 6C), consistent with previous observations
indicating that primary cultures of neurons are refractory to T1
reovirus infection (Dichter and Weiner, 1984). Thus, JAM-A is
fully dispensable for neural tropism of T3 reovirus.Figure 5. Reovirus T1L Is Incapable of Dissemination Following Peroral Inoculation of JAM-A/ Mice
(A) Newborn JAM-A+/+ and JAM-A/mice were inoculated perorally with 106 pfu T1L. At days 4, 8, and 12 after inoculation, mice were euthanized, organs were
resected, and viral titers were determined by plaque assay. Results are expressed as mean viral titers for six animals for each time point. Error bars indicate SD *,
p < 0.005 by Student’s t test. When all values are less than the limit of detection (spleen, liver, heart, and brain in JAM-A/mice), a Student’s t test P value cannot
be calculated.
(B) Newborn JAM-A+/+ and JAM-A/ mice were inoculated intracranially with 103 pfu T1L. At days 4, 8, and 12 after inoculation, mice were euthanized,
brains were resected, and viral titers were determined by plaque assay. Results are expressed as mean viral titers for 6–11 animals for each time point. Error
bars indicate SD *, p < 0.005 by Student’s t test.
(C and D) Newborn JAM-A+/+ and JAM-A/mice were inoculated perorally with 108 pfu T1L. At days 2 and 4 after inoculation, intestines of infected mice were
resected and processed for histopathology. Consecutive sections were stained with H&E or polyclonal reovirus antiserum. Representative sections of intestinal
villi at day 2 (C) and Peyer’s patches (PP) at day 4 (D) are shown. Boxes indicate areas of enlargement on the right and show villus epithelial cells.ll Host & Microbe 5, 59–71, January 22, 2009 ª2009 Elsevier Inc. 65
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JAM-A and Reovirus DisseminationFigure 6. JAM-A Is Required for Hematogenous Spread of Reovirus
(A) Newborn JAM-A+/+ and JAM-A/ mice were inoculated into the left hindlimb with 106 pfu of either T3D or T1L. At days 2, 4, 6, and 8 after inoculation, mice
were euthanized; left hindlimb, blood, and inferior spinal cord (ISC), including the thoracic and lumbosacral cord segments, were resected; and viral titers were
determined by plaque assay. Results are expressed as mean viral titers for six animals for each time point. Error bars indicate SD.
(B) Primary cortical cultures generated from E15 JAM-A+/+ and JAM-A/ embryos were cultured in vitro for 5–7 days, adsorbed with T3 reovirus at an MOI of
1000 pfu/cell, and incubated for 20 hr. Cells were stained with TUJ1 neural-specific marker to detect neurons (red), 40,6-diamidino-2-phenylindole (DAPI)
to detect nuclei (blue), and polyclonal reovirus antiserum to detect reovirus antigen (green) and visualized using indirect immunofluorescence microscopy.
Representative wells from triplicate experiments are shown.
66 Cell Host & Microbe 5, 59–71, January 22, 2009 ª2009 Elsevier Inc.
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JAM-A and Reovirus DisseminationReovirus Is Detected in Draining Lymph Nodes but Not
in the Bloodstream of JAM-A/ Mice Following Peroral
Inoculation
Following peroral inoculation, reovirus T1L disseminates to the
mesenteric lymph node (MLN) and spleen within 24 hr (Kauffman
et al., 1983). To determine whether JAM-A is required for
lymphatic or bloodstream dissemination, we inoculated WT
and JAM-A/ mice perorally with 108 pfu of T1L and quantified
viral titer in theMLN, spleen, and blood. In bothWTand JAM-A/
mice, viral titer in the MLN and spleen were detectable at early
times postinoculation and increased over the course of infection,
although T1L produced greater titers in WT versus JAM-A/
mice (Figure 7A). T1L titer in the blood of WT mice was detect-
able by day 2 postinoculation and increased thereafter
(Figure 7A). In sharp contrast, with the exception of one animal
per time point, there was no detectable titer of T1L in the blood
of JAM-A/ mice (Figure 7A). Similar results were obtained
with T3SA (Figure S4). Therefore, JAM-A is not required for
access to lymphatic routes of dissemination but is required for
the establishment of high titer viremia following peroral inocula-
tion of reovirus.
JAM-A Is Required for Efficient Infection of Primary
Endothelial Cells
Endothelial cells (ECs) line blood vessels and may serve as
a portal for reovirus entry into the circulation. To test whether
JAM-A is required for reovirus infection of ECs, we infected
primary mouse lung ECs prepared from adult WT and JAM-A/
mice with T1L and T3SA. The ECs displayed classic cobble-
stone morphology (Figure S5) and differed in JAM-A expression
(Figure S5). Both strains of reovirus were capable of infectingWT
but not JAM-A/ ECs over the course of a single infectious
cycle (Figures 7B and 7C). These results indicate that JAM-A
expression is required for efficient infection of mouse ECs by
reovirus.
DISCUSSION
By virtue of their capacity to infect the intestine and spread
systemically to the CNS, reoviruses offer an ideal experimental
system to define howneurotropic viruses interact with their hosts
at different steps in the disease process. We found that the IgSF
TJ protein JAM-A is required for reovirus spread from sites of
primary replication to target tissues in infected mice. Reovirus
strains disseminate systemically via hematogenous, neural, or
a combination of both routes (Kauffman et al., 1983; Tyler
et al., 1986; Morrison et al., 1991). Spread of T3D from hindlimb
to spinal cord, which occurs by neural routes (Tyler et al., 1986),
is not dependent on JAM-A. In contrast, spread of T1L from
hindlimb to spinal cord, which occurs by hematogenous routes
(Tyler et al., 1986), requires JAM-A expression. Thus, JAM-A
mediates hematogenous but not neural dissemination of
reovirus.
After introduction into the intestinal lumen, reovirus transcyto-
ses through intestinal epithelial M cells that overlie PPs (WolfCelet al., 1981; Newberry, 2008). Reovirus infects PP cells (Wolf
et al., 1981; Bass et al., 1988) and is thought to spread through
lymph or blood vessels to villi surrounding PPs, where significant
replication occurs in epithelial cells (Rubin et al., 1985). Reovirus
is detectable in MLN and spleen within 24 hr postinoculation and
found subsequently in the blood and virtually every tissue in the
infected host (Kauffman et al., 1983). Viruses can establish
viremia by transport through lymphatics, infection of ECs,
and infection of blood leukocytes (Nathanson and Tyler,
1997). However, mechanisms of reovirus viremia are unknown.
Titers of T1L and T3SA in the blood are diminished or undetect-
able in all JAM-A/mice following peroral inoculation. However,
both strains of reovirus are capable of reaching the spleen in
JAM-A/mice following peroral inoculation, albeit in diminished
titers in comparison to those inWT animals. Since the only hema-
togenous pathway from the intestine to the spleen is via the
blood, the presence of virus in the spleen of JAM-A/ mice
following peroral inoculation indicates that some virus likely
escapes into the bloodstream in these animals, although titers
in blood are reduced below the limit of detection for most JAM-
A/ mice. Lymphatic spread of T1L from intestine to MLN is
diminished but not abolished in JAM-A/ animals in comparison
to WT. Most strikingly, JAM-A is required for infection of primary
ECs. Thus, two important routes for the establishment of
viremia—spread through lymphatics and infection of ECs—are
impaired in JAM-A/ mice.
How might JAM-A promote entry of reovirus into the lymph
and bloodstream? We envision three possibilities. First, virus
binding to JAM-Amight lead to productive infection of lymphatic
and blood ECs with subsequent apical release of progeny virions
into the circulation. In the case of murine cytomegalovirus, the
majority of viral load found in the bloodstream within the first
48 hr postinfection originates in ECs (Sacher et al., 2008). In
support of this possibility, reovirus infection of polarized airway
epithelial cells leads to apical release of virus with little detect-
able cytopathic effect (Excoffon et al., 2008). Second, JAM-A
might facilitate trafficking of reovirus particles between ECs,
analogous to interactions of adenovirus with polarized cells.
When the adenovirus attachment protein, fiber, interacts with
its TJ-associated receptor, coxsackievirus and adenovirus
receptor, junctional integrity is disrupted and virus moves freely
between cells (Walters et al., 2002). Although reovirus does not
appear to disrupt epithelial TJs (Excoffon et al., 2008), it is
possible that reovirus disrupts JAM-A interactions in endothelial
TJs to allow bloodstream entry. Third, JAM-A might permit
reovirus transport through ECs via a transcellular pathway. Cav-
eolae-mediated transcytosis efficiently transports extracellular
molecules across ECs in a receptor-specific manner (Predescu
et al., 2007). Adeno-associated virus and HIV-1 can penetrate
ECs via transcytosis (Gujuluva et al., 2001; Di Pasquale and
Chiorini, 2006). Likewise, reovirus may transcytose through
ECs using a JAM-A-dependent mechanism.
Despite the important functions of JAM-A in the host,
JAM-A/ mice are viable, with normal organ development and
morphology (Cera et al., 2004). In addition, these mice do not(C) JAM-A+/+ and JAM-A/ cortical cultures were cultured in vitro for 5–7 days; adsorbed with T1L, T3D, or T3SA at an MOI of 1000 pfu/cell; and incubated for
20 hr. The percentage of infected cells was quantified by dividing the number of neurons exhibiting reovirus staining by the total number of cell nuclei exhibiting
DAPI staining in three fields of 4003 view for triplicate experiments. Fields of view contained between 200 and 600 nuclei. Error bars indicate SD.l Host & Microbe 5, 59–71, January 22, 2009 ª2009 Elsevier Inc. 67
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JAM-A and Reovirus DisseminationFigure 7. JAM-A Is Required for Viremia and Efficient Reovirus Infection of Endothelial Cells
(A) Newborn JAM-A+/+ and JAM-A/mice were inoculated perorally with 108 pfu of T1L. At days 1, 2, 4, and 6 after inoculation, mice were euthanized; mesen-
teric lymph node (MLN), blood, and spleen were collected; and viral titers were determined by plaque assay. Results are expressed asmean viral titers for three to
eight animals for each time point. Error bars indicate SD.
(B) Primary ECs generated from JAM-A+/+ and JAM-A/mice were adsorbedwith either reovirus T1L or T3SA at anMOI of 100 pfu/cell and incubated for 20 hr.
Cells were stained with polyclonal reovirus antiserum to detect reovirus antigen (green) and 40,6-diamidino-2-phenylindole (DAPI) to detect nuclei (blue) and
visualized using indirect immunofluorescence microscopy. Representative wells from triplicate experiments are shown.
(C) JAM-A+/+ and JAM-A/ primary ECs were adsorbedwith T1L or T3SA at MOIs of 1, 10, and 100 pfu/cell and incubated for 20 hr. The percentage of infected
cells was quantified by dividing the number of cells exhibiting reovirus staining by the total number of cell nuclei exhibiting DAPI staining in entire wells of 96-well
plates for triplicate experiments. Wells contained between 200 and 1600 nuclei. Error bars indicate SD *, p < 0.05 as determined by Student’s t test.68 Cell Host & Microbe 5, 59–71, January 22, 2009 ª2009 Elsevier Inc.
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neutrophils, or monocytes (Cera et al., 2004). The intestinal
mucosa of JAM-A/ mice demonstrates normal expression of
occludin and claudin-2, upregulation of claudin-10 and clau-
din-15, and increased permeability to small molecules, but not
bacteria (Laukoetter et al., 2007). Alterations in the ratios of
claudin-10 and claudin-15 can affect the permeability of the
epithelium to small molecules (Tsukita et al., 2001; Van Itallie
and Anderson, 2006), but the normal expression of TJ structural
proteins such as occludin, zonula occludens-1, and E-cadherin
(Mandell et al., 2005) suggests that the absence of JAM-A
does not lead to overt changes in TJ structure or assembly (Lau-
koetter et al., 2007). Reovirus virions are 25,000 times larger
than the small molecules used in the permeability assays
reported previously (Laukoetter et al., 2007) and roughly the
size of a TJ. Therefore, we do not think the absence of JAM-A
leads to the free flux of reovirus between intestinal epithelium
and underlying tissue. This conclusion is supported by intestinal
micrographs demonstrating that the absence of JAM-A does not
alter the histologic pattern of reovirus intestinal infection. More-
over, any alterations in the permeability of JAM-A/ intercellular
junctions clearly do not enhance the capacity of reovirus to
access the lymphatic circulation and the bloodstream following
replication in the intestine.
The exquisite neural tropism of reovirus in newborn mice is
restricted to T3 strains (Raine and Fields, 1973). The viral gene
encoding attachment protein s1 is the major determinant of
reovirus neurovirulence (Weiner et al., 1980b). T3SA does not
bind sialic acid (Barton et al., 2001a), a carbohydrate coreceptor
used by some T3 reovirus strains (Dermody et al., 1990). Our
finding that JAM-A is not required for reovirus T3SA replication
in the intestine or brain suggests the existence of novel receptors
for reovirus at those sites. In parallel with these findings, analysis
of histologic brain sections indicates that T3SA infects the
same regions of WT and JAM-A/ mouse brains: the cortex,
CA2–CA4 regions of the hippocampus, the thalamus, and
cerebellar Purkinje cells. This regional tropism is identical to
that observed using a sialic acid-binding T3 reovirus strain (Ri-
chardson-Burns and Tyler, 2004). Moreover, genetic deletion
of JAM-A does not alter reovirus infection of primary cultures
of neurons. Based on findings reported here, we hypothesize
that reovirus replication in neurons is mediated by a serotype-
specific receptor other than JAM-A or sialic acid. In addition,
since both T1 and T3 reovirus strains can replicate in the intestine
of JAM-A/mice, we propose that reovirus infection at that site
is mediated by a serotype-independent receptor.
Nectin-1, also called poliovirus receptor-related 1 (PVRL1), is
a widely expressed IgSF adhesion molecule (Haarr et al., 2001)
that serves as a receptor for herpes simplex virus (HSV) (Cocchi
et al., 1998; Geraghty et al., 1998). As with reovirus and JAM-A,
nectin-1 is required for HSV-2 virulence following intravaginal
inoculation (Taylor et al., 2007). However, unlike reovirus and
JAM-A, nectin-1 is required for HSV-2 replication at the site of
primary replication, the vaginal epithelium (Taylor et al., 2007).
Spread of HSV-2 to the dorsal root ganglia and spinal cord
from vaginal epithelium is impaired in Pvrl1/ mice. Although
some of these animals succumb to HSV infection, Pvrl1/
mice are protected from development of external signs of
disease, including hair loss, inflammation, and skin lesions,Celindicating that nectin-1 mediates dissemination from vaginal
epithelium to perineal skin and surrounding areas (Taylor et al.,
2007). Thus, IgSF member nectin-1 is required for HSV-2
infection of the vaginal epithelium and spread to both perineal
skin and the CNS.
The finding that an individual viral receptor can mediate
a specific step in pathogenesis has important implications for
antiviral strategies. For example, while genetic deletion of
JAM-A protects mice from reovirus disease following peroral
inoculation, these animals are capable of viral transmission to
new hosts. Uninoculated littermates of infected JAM-A/
mice develop high titers of reovirus in the intestine, suggesting
that viral shedding occurs in infected JAM-A/ mice. In this
model, pharmacological blockade of reovirus-JAM-A interac-
tions would diminish disease in treated individuals but have no
effect on viral transmission between hosts, an observation that
merits consideration in other viral diseases.
Establishment of viremia is a poorly understood process for
most viruses. Our work shows that reovirus viremia depends on
virus interactions with JAM-A in a limited subset of host tissues.
Further dissection of how JAM-A promotes vascular access
may provide clues about mechanisms of systemic dissemination
of adenovirus, coxsackievirus, HSV, and poliovirus, which also
employ junction-associated IgSF proteins as receptors. More-
over, our finding that a broadly expressed receptor mediates an
exquisitely specific aspect of viral pathogenesis suggests that
virus-host interactions require multiple receptors that serve
unique functions at each step of the disease process.
EXPERIMENTAL PROCEDURES
Cell Lines, Viruses, and Antibodies
L cells were maintained as described (Barton et al., 2001a). Reovirus strains
T1L and T3D are laboratory stocks. T3SA was generated as described
(Barton et al., 2001a). Virus was purified after growth in L cells by CsCl-gradient
centrifugation (Furlong et al., 1988). Viral titers were determined by either
plaque assay (Virgin et al., 1988) or fluorescent focus assay (Barton et al.,
2001a). Immunoglobulin G (IgG) fractions of rabbit antisera raised against
T1L and T3D (Wetzel et al., 1997) were purified by protein A Sepharose (Barton
et al., 2001a). Fluorescently conjugated secondary Alexa antibodies were
obtained from Molecular Probes (Invitrogen).
Mice
C57BL/6J (WT, JAM-A+/+) mice were obtained from Jackson Laboratory.
JAM-A/mice (Cera et al., 2004) were provided by T. Sato (Cornell University;
New York, NY) and backcrossed for ten generations on a C57BL/6J back-
ground strain. Disruption of the JAM-A gene was confirmed by PCR and
immunoblotting.
MEFs and Primary Cortical Cultures
MEFs were maintained in Dulbecco’s modified Eagle’s medium (GIBCO)
supplemented to contain 10% FBS (GIBCO), 13 MEM nonessential amino
acids, 2 mM L-glutamine, 0.1 mM 2-mercaptoethanol, 20 mM HEPES,
100 units/ml penicillin, 100 mg/ml streptomycin, and 0.25 mg/ml amphotericin
B. Cells at passages 3–5 were used for the experiments in this study.
Primary mouse cortical cultures were derived from cortices of E15 WT and
JAM-A/ embryos as described in the Supplemental Data. Viable cells were
plated at a density of 2.75 3 105 cells/ml in 24-well plates (Costar) or on glass
coverslips placed in 24-well plates (BD Biosciences). Wells were treated prior
to plating with a 10 mg/ml poly-D-lysine solution (BD Biosciences) and
a 1.64 mg/ml laminin solution (BD Biosciences). Cultures were incubated for
the first 24 hr in neurobasal medium (GIBCO) supplemented to contain 10%
FBS (GIBCO), 0.6 mM L-glutamine, 50 units/ml penicillin, and 50 mg/mll Host & Microbe 5, 59–71, January 22, 2009 ª2009 Elsevier Inc. 69
Cell Host & Microbe
JAM-A and Reovirus Disseminationstreptomycin. Cultures were thereafter maintained in neurobasal medium sup-
plemented to contain 13 B27 (GIBCO), 50 units/ml penicillin, and 50 mg/ml
streptomycin. A 50% medium change was performed every 3–4 days.
Neurons were allowed to mature for 7 days prior to use.
Primary mouse pulmonary microvascular ECs were generated and cultured
as described in the Supplemental Data. Cells at passages 3–4 were used for all
experiments.
Viral Infectivity
Monolayers of cells were adsorbedwith reovirus at variousMOIs, fixed after 20
hr, visualized by indirect immunofluorescence, and quantified as described
(Barton et al., 2001a).
Virus Replication
Monolayers of cells in 24-well plates (Costar) were adsorbed with reovirus at
an MOI of 2 pfu/cell, washed with PBS, and incubated for various intervals.
Cells were frozen and thawed twice prior to viral titer determination by plaque
assay using L cells. Viral yields were calculated according to the following
formula: log10 yieldtx = log10 (pfu/ml)tx  log10 (pfu/ml)t0, where tx is the time
postinfection.
Infection of Mice
Newborn mice weighing 1.5–2 g were inoculated perorally (Rubin and Fields,
1980), intracranially (Tyler et al., 1985), or intramuscularly (Tyler et al., 1986)
with purified reovirus diluted in PBS. For analysis of virulence, mice weremoni-
tored for weight loss and symptoms of disease for 21 days postinoculation
and euthanized when moribund. For analysis of viral replication, mice were
euthanized at various intervals following inoculation, and organs were har-
vested into 1 ml of PBS, frozen and thawed three times, and homogenized
by sonication. For analysis of viremia, mice were decapitated at various inter-
vals following inoculation, and whole blood was collected from the neck into
a 1 ml syringe containing 100 ml Alsever’s solution (Sigma). Blood in Alsever’s
solution was frozen and thawed three times and homogenized by sonication.
Viral titers in organ homogenates and bloodwere determined by plaque assay.
Animal husbandry and experimental procedures were performed in accor-
dance with Public Health Service policy and approved by the Vanderbilt
University School of Medicine Institutional Animal Care and Use Committee.
Histology
Newbornmice weighing 1.5–2 gwere inoculated intracranially or perorally with
reovirus diluted in PBS. At various intervals following inoculation, mice were
euthanized and organs were resected. Selected organs were incubated in
10% formalin at RT for 24 hr followed by incubation in 70%ethanol at RT. Fixed
organs were embedded in paraffin, and consecutive 6 mm sections were
stained with H&E for evaluation of histopathologic changes or processed for
immunohistochemical detection of reovirus protein. The left hemispheres of
brains were processed for plaque assay.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, two tables, and five figures and can be found
online at http://www.cell.com/cellhostandmicrobe/supplemental/S1931-
3128(08)00398-3.
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